MXCT vs VMC
MaxCyte Inc (MXCT) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
MXCT currently screens at market cap $124.3M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the MXCT and VMC stock pages for the full models.
Not investment advice.